BioMarin Pharmaceutical
BMRN
#1885
Rank
ยฃ7.93 B
Marketcap
ยฃ41.31
Share price
-0.79%
Change (1 day)
-19.85%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): ยฃ0.51 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are ยฃ3.09 Billion. In 2024 the company made an earning of ยฃ0.39 Billion, an increase over its 2023 earnings that were of ยฃ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.51 B30.55%
2024 ยฃ0.39 B187.31%
2023 ยฃ0.13 B26.07%
2022 ยฃ0.10 B-298.51%
2021 -ยฃ55.06 Million78.04%
2020 -ยฃ30.93 Million-55.36%
2019 -ยฃ69.29 Million-33.56%
2018 -ยฃ0.11 Billion297.78%
2017 -ยฃ26.22 Million-95.68%
2016 -ยฃ0.61 Billion437.12%
2015 -ยฃ0.12 Billion23.91%
2014 -ยฃ91.25 Million-29.25%
2013 -ยฃ0.13 Billion49.23%
2012 -ยฃ86.43 Million171.11%
2011 -ยฃ31.88 Million103.01%
2010 -ยฃ15.71 Million-3903.54%
2009 ยฃ0.41 M-98.31%
2008 ยฃ24.42 M-189.7%
2007 -ยฃ27.23 Million51.02%
2006 -ยฃ18.03 Million-61.58%
2005 -ยฃ46.93 Million-56.59%
2004 -ยฃ0.11 Billion95.13%
2003 -ยฃ55.4 Million12.09%
2002 -ยฃ49.42 Million73.19%
2001 -ยฃ28.54 Million18.32%
2000 -ยฃ24.12 Million19.65%
1999 -ยฃ20.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
ยฃ6.64 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.38 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ79.67 Million-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ20.06 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ3.64 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ0.20 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA